ClearPoint Neuro
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
120 S Sierra Ave Ste 100, Solana Beach, ...Phone Number
(888) 287-9109Website
www.clearpointneuro.comRevenue
$42.3 MillionStock Symbol
CLPTIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About ClearPoint Neuro
ClearPoint Neuro Inc is a medical device company that specializes in developing and commercializing platforms for minimally invasive surgical procedures in the brain. The company provides navigation and delivery systems that enable precise targeting and real-time MRI guidance during neurosurgical interventions. ClearPoint Neuro's technology supports various therapeutic applications including deep brain stimulation, laser ablation, biopsy procedures, and drug delivery to treat neurological conditions. The company's solutions are designed to enhance surgical accuracy, improve patient outcomes, and expand treatment options for complex brain disorders. ClearPoint Neuro serves neurosurgeons and medical institutions seeking advanced tools for image-guided neurosurgery.Explore more
ClearPoint Neuro Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ClearPoint Neuro your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if ClearPoint Neuro had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ClearPoint Neuro
Check out if ClearPoint Neuro is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when ClearPoint Neuro launches new products
Earning: See what the market has to say on ClearPoint Neuro recently announced quarterly report
Check if ClearPoint Neuro has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ClearPoint Neuro has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ClearPoint Neuro, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at ClearPoint Neuro
Find 3 more new buyers
Compare Similar Companies to ClearPoint Neuro
Compare insights from companies similar to ClearPoint Neuro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ClearPoint Neuro is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ClearPoint Neuro is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ClearPoint Neuro.
ClearPoint Neuro financials insights
Gather financial insights about ClearPoint Neuro, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Debt
$1.3M
2020
Debt
$350K
Debt
$7.5M
2021
Stock Offering
$43.4M
2025
Other Financing Round
$110M
2026
Stock/Share Issuance
$17.9M
ClearPoint Neuro Tech Stack
A closer look at the technologies used by ClearPoint Neuro
Most Recent Scoops
Person-Based
Earnings, Finance
Project
ClearPoint Neuro has announced that its new CAL facility in Torrey Pines, California offers significantly expanded capacity compared to its prior subleased facility, including GLP capabilities, new services such as histology, and the ability to conduct larger and simultaneous studies, with internal projections suggesting the facility could support up to $60 million in annual revenue capacity.
Spending/Investment, Capacity Planning, Laboratory Operations
Hiring Plans
ClearPoint Neuro has announced plans to hire clinical specialists globally, including in the United States, European Union, Canada, and Japan, to support Phase III and commercial drug delivery cases over the next 12 to 15 months.
Hiring Plans, Pharmaceuticals, Clinical Operations
Project
ClearPoint Neuro has announced that its new CAL facility in Torrey Pines, California is currently in a showcase phase for H2 2026, with biopharma partners being introduced to the facility and its capabilities, equipment deliveries expected by end of 2026 or early 2027, and larger studies anticipated to begin running through the facility in H2 2027.
Laboratory Operations, Pharmaceuticals
Earnings
Earnings, Finance, Financial Operations, Tax
ClearPoint Neuro News & Media
ClearPoint Neuro Q1 2026 Earnings Call Transcript
ClearPoint Neuro (NASDAQ:CLPT) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consultation. View the webcast at https://event.choruscall.com/mediaframe/webcast.html?webcastid=IjzOoM7l Summary ClearPoint Neuro reported record revenue of $12.1 million for Q1 2026, with a 43% growth rate driveWhat Creates a Long-Term Growth Opportunity for ClearPoint Neuro (CLPT)?
Minot Light Capital Partners, an investment management company, released its Q3 2025 investment letter. A copy of the letter can be downloaded here. In the quarter, Minot Light generated solid returns for limited partners, with a net of 7.6%. However, on a net basis, the performance underperformed the benchmarks, particularly the micro-cap benchmark’s 17.1% return. […]Here’s What Boosted ClearPoint Neuro (CLPT) in Q3
Deep Sail Capital, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The fund returned 5.8% net of fees in the third quarter, outperforming the Russell 2000 Mid Cap Growth Index’s 0.4% return and lagging the Russell 2000 Index’s 12.4% gain. YTD, the fund returned 18.1% […]ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsJoseph Burnett - President, CEO & DirectorDanilo...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ClearPoint Neuro
Sign Up For FreeTo access detailed company insights
ClearPoint Neuro Inc is a medical device company that specializes in developing and commercializing platforms for minimally invasive surgical procedures in the brain. The company provides navigation and delivery systems that enable precise targeting and real-time MRI guidance during neurosurgical interventions. ClearPoint Neuro's technology support... Read More
